Our mission is to
Accelerate breakthrough antibody therapeutics harnessing the superior power of nature’s elite immune responses
Human antibodies, unlocked with precision
Turning elite immunity into lifesaving therapies
At Abvion, we revolutionize antibody discovery by tapping into the power of elite human immune responses. Through direct protein-level discovery, we capture battle-tested antibodies directly from biofluids, including archived biobank materials.
Our AbDirect platform delivers unmatched sensitivity and precision, yielding mature, in vivo-evolved sequences with superior efficacy and tolerability. Such antibodies represent ideal blueprints for therapeutics that address real patient needs. Read more about how we are transforming human antibody discovery.
Backed by leading innovators
Abvion works with leading partners to advance our mission in human-derived therapies.
Our founding team
Dedicated to antibody innovation
"Nature holds the key to better health, and our unique approach to understanding and utilizing the power of natural immune responses sets us apart in the biotech industry."
Maurits den Boer - CEO & co-founder
"We are pursuing the development of transformative therapies, building on a foundation of cutting-edge proteomics technologies and the power of natural antibodies."
Albert Heck - CTO & co-founder
News
Latest antibody insights
